Somatostatin Antagonists for Radioligand Therapy of Nonendocrine Tumors

Elif Hindié, Paolo Zanotti-Fregonara, Clément Morgat
J Nucl Med. 2017-08-17; 59(3): 544-544
DOI: 10.2967/jnumed.117.199158

PubMed

1. J Nucl Med. 2018 Mar;59(3):544. doi: 10.2967/jnumed.117.199158. Epub 2017 Aug 17.

Somatostatin Antagonists for Radioligand Therapy of Nonendocrine Tumors.

Hindié E(1), Zanotti-Fregonara P, Morgat C.

Author information:
(1)Bordeaux University Hospital 33405 Bordeaux, France E-mail:
.

Comment on
J Nucl Med. 2017 Feb;58(2):300-306.

DOI: 10.2967/jnumed.117.199158
PMID: 28818985 [Indexed for MEDLINE]